MAINE: How big is Maine’s new adult-use cannabis industry? According to the Maine Office of Marijuana Policy, there are 17 new adult use conditional licenses. The breakdown includes seven marijuana stores, five cultivation facilities, four products manufacturing facilities, and one testing facility.
New company brings together cannabis industry leaders including attorney-scientist Dale Hunt, researcher-physician Ethan Russo, and botanist-author Robert C. Clarke
CALIFORNIA: Cannabis industry pioneers, Dale Hunt, PhD, JD, Ethan Russo, MD, and Robert C. Clarke have joined forces to create Breeder’s Best, the first cannabis company to focus on intellectual property (IP) protection for independent plant breeders and licensing IP for access to markets worldwide. Breeder’s Best brings a global plant-licensing model, proven successful in other agriculture industries, to cannabis.
The liberalization of global cannabis laws and growing public acceptance of cannabis have created a rapidly escalating demand for cannabis flower, as well as therapeutics and products made with cannabis. According to a report by Prohibition Partners, the international cannabis industry is projected to grow to more than $103.6 billion by 2024.
While the cannabis industry presents significant opportunity, there exists a critical disconnect that separates the creativity of breeders from the markets that are demanding products with unique and proven genetic profiles. Additionally, there is typically very little IP protection to support good partnerships between breeders and cannabis brands. Breeder’s Best will connect these two key stakeholders while legally protecting the genetic inventiveness of breeders.
Breeder’s Best founder and CEO Dale Hunt says, “Our mission is to connect the best Cannabis genetics to the greatest needs and most promising commercial opportunities. To do that, we have assembled an unparalleled team of experts with deep experience at every level of the cannabis supply chain. As the industry matures, Breeder’s Best will be positioned to meet the demands of the increasingly professional and GMP-oriented marketplace while doing business in a way that benefits breeders and directs profitable and reliable business to growers who may otherwise be left behind. With our vision, team, model, know-how, and relationships, Breeder’s Best is poised to become the global leader in patented cannabis genetics and related products.” Dr. Hunt has been practicing IP law for 23 years. He has a PhD in plant cellular and molecular biology and has obtained thousands of patents and plant variety rights for his clients in more than 30 countries.
“Cannabis use is finally normalizing. At Breeder’s Best, we present independent Cannabis breeders the opportunity to protect their unique varieties and assist them in placing those genetics in lucrative markets. This is a great service to breeders who would prefer to focus on the art and science of breeding, instead of dealing with the mechanics of commercialization,” said Breeder’s Best Director of Agronomy and Genetics, Robert C. Clarke. Mr. Clarke is a 40-year cannabis industry veteran, revered for his books Marijuana Botany, published in 1982, and Cannabis: Evolution and Ethnobotany, published in 2013.
The Cannabis plant produces over 450 chemical components, many of which are potentially therapeutic. However, decades of cannabis prohibition have resulted in a lack of genetic diversity worldwide and a predominance of only a small fraction of potential agents.
“We have just begun to scratch the surface of everything that cannabis can do to improve and enhance our lives,” said Dr. Ethan Russo. “That’s what Breeder’s Best will do. Identifying, selectively breeding for and utilizing specific chemical components will truly transform medicine in the coming decades.” Dr. Russo is a board-certified neurologist, preeminent medical cannabis expert, author of more than 50 peer-reviewed medical journal articles and a veteran of GW Pharmaceuticals where he served as Senior Medical Advisor as well as the Sativex® and Epidiolex® clinical trial Study Physician and Medical Monitor.
About Breeder’s Best: Breeder’s Best is a privately held Cannabis IP genetics company organized as a B Corporation to demonstrate our commitment to independent Cannabis breeders and to meeting the worldwide needs of patients and consumers for superior products. To learn more about Breeder’s Best visit www.breedersbest.com.
MJNews Network Exclusive Report
By Lorelei Caudill
Are we potentially growing our own cure for this global pandemic?
Is the United States the most well-equipped country to potentially conduct one of the most extensive case studies in our world’s history?
Let’s take a more in-depth look at why the answer may be a yes.
In these times of uncertainty, globally, we are starting to look at science and data to help guide critical decisions to determine our new social norm needs. Cannabis is under the microscope on a global level since the beginning of this pandemic.
- Studies conducted with complete summary – Seattle, Washington San Antonio, Texas Iran Indonesia Israel – Jerusalem Alberta, Canada
- Studies in progress – Miami Florida Israel
- Published Scientific Hypothesis – American Study for Microbiology
- Press Release – Ontario
- Morocco Medicinal Plants with like compounds showing promise as well
We are leaning on technology, data, and statistics on how and when to reopen our states and communities. We look to science to help us learn more about how the virus is spread. Some of the world’s best doctors have now taught us “How to wash our hands.” It seems a little crazy, right?
When we think of COVID19 and Cannabis, we need to do the same and lean scientific data from successful cannabis studies in the past (which is quite a bit, despite what many think) and watch the continuing studies with COVID19 scientists are conducting today on a global level.
Initially, some may say, “Nope, I consume cannabis, and I tested positive” (to be honest in my current COVID Survey has only been one person since I published on March 21st).
Disregarding Cannabis as a potential to help with this global pandemic, is like saying you wash your hands, and you still contracted COVID19.
Realistically everyone’s next questions would be based on scientific data:
- What did you wash your hands with?
- How long did you wash your hands?
- How often did you wash your hands?
We need to think the same way and apply theory and scientific data to Cannabis:
- What cannabis product did you consume?
- How frequently did you consume Cannabis?
- What form factor of Cannabis do you consume? (inhaled, edibles, tinctures, etc.)
Cannabis plants are not all created equally. The plant contains more than 110 possible cannabinoids and over 120 terpenes, all of which work differently in the human body. To add yet another layer of complexity, research has found certain cannabinoids work differently with other cannabinoids/terpenes. This variable is called the entourage effect.
According to Strain Genie :
- Terpenes such as alpha-pinene, limonene, and isoprene can cause irritation to the upper respiratory system. However, they can provide anti-infectious effects for bronchitis. Both alpha-pinene and beta-pinene were found to have antimicrobial and antibacterial properties.
- Beta-Caryophyllene provides a balancing act of the various cannabinoids, and terpenes creates an environment for synergism and homeostasis.
- The NIH has a study posted from 2008 – Antibacterial Cannabinoids From Cannabis Sativa showing All five major cannabinoids (cannabidiol (1b), cannabichromene (2), cannabigerol (3b), Delta (9)-tetrahydrocannabinol (4b), and cannabinol (5)) showed potent activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.
In addition to how Cannabis interacts with our human endocannabinoid system, there are other scientific data points to consider, our individual DNA. Research Scientist Nicco Reggente Ph.D., co-founder of Strain Genie, takes cannabis science to a whole new level by providing insight and data required to understand how we can use human DNA to further analyze how an individual metabolizes Cannabis, including the infamous intoxicating compound THC.
Strain Genie analyzes over 450 genetic biomarkers to recommend the best consumption methods and ratios per consumer. With this type of data and information, we can be less fearful of Cannabis as a potential aid in COVID19, knowing we will not have to walk around high or heavily sedated to prevent contraction and spread. It may even help you wash your hands a little longer!
Strain Genie uses DNA biomarkers to align cannabinoids and terpenes within the cannabis plant the help tame or mitigate much of the “high” with Cannabis by providing a custom THC: CBD ratio along with additional terpenes to pair when looking to combat things like cannabis-induced anxiety in individuals that may also be genetically predisposed to having depression, PTSD, or OCD.
Let’s Put Actual COVID19 Under A Microscope With Cannabis:
Next, let’s apply this potential:
As you can see, the public-facing laboratory test for each harvest in our legal markets holds valuable data. This is the type of data we can use to help propel us forward when thinking about Cannabis and the potential with COVID19. Cannabis consumers may request their products laboratory test upon purchase.
Could this lead to one of the most extensive human case studies in cannabis history?
Slight curveball, not every state-level legal growing operation, is required to provide a terpene content and potency profile. Currently, California, Michigan, Connecticut, and our nation’s capital District of Columbia are the only places that require a terpene profile on top of the cannabinoid profile per harvest; this makes them prime candidates to further research!
In closing, I believe we are much closer than ever to have the ability to quickly link cannabis COVID19 when looking for ways to prevent the spread, and potential treatments. We may find Cannabis as a temporary relief until a vaccine is created. This would allow us to open up more safely and to mitigate much of the risk. The world’s scientists, cultivators, and our states rigorous regulations and testing requirements that have progressed us forward while leaving a valuable data trail in a moment when time is not the most kind.
Caveats – AS ALWAYS PLEASE CONSULT WITH YOUR PRIMARY CARE PHYSICIAN BEFORE PURCHASING OR CONSUMING CANNABIS BASED PRODUCTS
- Smoking cannabis is unfavorable, regardless.
- Consuming cannabis may pose a risk to pregnant women.
- Products with THC are not recommended for consumers with some cancer types where tumors are present.
- Be aware Cannabis is known to have interactions with other medications.
About Lorelei Caudill – Cannabis Science 101 – www.cannabisque.org
I am a mother, a sister, a daughter, and a granddaughter. My family and I have personal experience with the medicinal value of Cannabis.
Over the past few years, I have dedicated much of my spare time to understand the science behind the “how” and “why” Cannabis works with the human body. Why do some consumers benefit from the medicinal value of Cannabis while others do not? Why would one product have little to no results, while others not only relieve symptoms but help with the root condition?
My goal with Cannabisque is to provide an unbiased platform of educational content created directly from highly regulated studies to educate Cannabis curious consumers globally as we learn more about this miracle plant the promise scientists are documenting in research today.
The Company continues to expect to incur approximately $700-800MM pre-tax charge in Q4 Fiscal 2020.
CANADA: Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NYSE:CGC) today announced a series of global operational changes designed to further optimize production, better align supply and demand, and improve efficiencies in its global operations. As part of its ongoing strategic review of the business, the Company announced today the following changes to its operations:
- Africa: Canopy Growth has exited its operations in South Africa and Lesotho, transferring ownership of all of its African operations.
- Canada: The Company will shut down its indoor facility in Yorkton, Saskatchewan, to further align production in Canada with market conditions.
- Latin America: Canopy Growth will cease operations at its cultivation facility in Colombia, moving to an asset-light model that leverages local suppliers for raw materials and Procaps for formulation and encapsulation activities as outlined in the previously announced agreement between the two companies. These activities will support the position of Colombia as the Company’s LATAM production hub and the ongoing development of its cannabis industry.
- United States: Canopy Growth will cease its farming operations in Springfield, New York, due to current market demand for hemp.
“When I arrived at Canopy Growth in January, I committed to conducting a strategic review in order to optimize our cost structure and reduce our cash burn,” said David Klein, CEO, Canopy Growth. “I believe the changes outlined today are an important step in our continuing efforts to focus the Company’s priorities, and will result in a healthier, stronger organization that will continue to be an innovator and leader in this industry. I want to sincerely thank the members of the teams affected by these decisions for their contributions in helping build Canopy Growth.”
The Company continues to expect, based upon information currently available to management, to record estimated pre-tax charges of approximately $700-800MM in the quarter ending March 31, 2020. This relates to this announcement and previous announcements, as well as any additional changes made during the organizational and strategic review. The organizational changes announced today include a headcount reduction of approximately 85 full-time positions.
All figures reported above with respect to the quarter ending March 31, 2020 are preliminary and are unaudited and subject to change and adjustment as the Company prepares its consolidated financial statements for the year ending March 31, 2020. Accordingly, investors are cautioned not to place undue reliance on the foregoing information. The Company does not intend to provide preliminary results in the future. The preliminary results provided in this news release constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation, are based on several assumptions and are subject to a number of risks and uncertainties. Actual results may differ materially. See “Notice Regarding Forward Looking Statements”.
We all need to make money to survive. Some ways of making money are more comfortable when compared to others. If you’re someone who wouldn’t like to work a nine-hour shift to bring home money, then this article is perfect for you. Allow us to apprise you of 4 plants you can grow in your backyard or garden that will help you win your bread and butter with no hardship involved.
Mushrooms are not only delicious but very profitable too. The two most famous gourmet mushrooms that are lucrative are shiitake and oyster. These two mushrooms can be found in markets, both dry and fresh. A great advantage is that you can grow these two exotic mushrooms in your home without the need for fertile soil. You can grow them on waste products like sawdust or coffee grounds. Fortunately, it only takes 6-8 weeks for the mushrooms to mature. Hence you can earn quickly off them. Currently, these gourmet mushrooms for $7 a pound. This will equal to $17,000 in a 10×10 space! Imagine making such an income from growing fungi right at home.
Marijuana is probably equivalent in status to the ‘rose.’ Everyone knows about it, and everyone has a love for it. Believe it or not, people are growing marijuana at home. Marijuana can earn you some big money. One reason is that you can sell it or use it for your own recreational or medicinal benefit. There are several strains of marijuana, as well. We suggest you plant a strain at home that is high in demand, such as OG Kush, Pineapple Express, Bruce Banner, White Widow, Orange Sherbet, and more. Visit the ILGM blog to get to know more about how to grow marijuana at home.
Any or Every Herb
Herbs have been used for thousands of years for medicinal purposes. Herbs like thyme, cardamom, cumin, coriander, rosemary, basil, and many more are viral. These herbs are used in Indian, Italian, Moroccan, and Latin American cuisines so you can imagine their popularity. Without these herbs, the savory taste of dishes belonging to each cuisine will not be the same. Apart from cooking, herbs are excellent in providing medicinal benefits. For example, lavender is used in aromatherapy since it promotes wellness and calmness. Start by growing oregano, parsley, basil, and mint in your garden or kitchen since they are the easiest to grow.
Garlic has voted in the top 10 most sought after vegetables in the world. Now you shouldn’t grow just any garlic in your backyard – you need to grow ‘gourmet garlic.’ Gourmet garlics have bulbs that are uniform in shape and large in size. There are three types of gourmet garlic: rocambole, purple stripe, and porcelain. The flavor of such garlic is savory, which explains why they are in demand in fancy restaurants. This intense flavor also sets them apart from the ordinary garlic. Growing such garlic in your home can help you make $8-$10 per pound!
COLORADO: Denver city officials didn’t exactly embrace Amendment 64 before voters statewide — and heavily in Denver — approved recreational marijuana legalization in 2012.
But Mayor Michael Hancock and his administration is taking a new opportunity to exhibit pride in the city’s regulation of the retail cannabis industry.
This week the city’s Office of Marijuana Policy, headed by Ashley Kilroy, announced that it will host a two-day “marijuana management symposium” Nov. 5-6 at the Colorado Convention Center. It has invited attendees from across the country, largely targeting local governments that also are adjusting to legalized marijuana or might face a similar challenge on the horizon.
ARIZONA: Arizona’s medical-marijuana patients now can patronize newly opened dispensaries in Reno and Las Vegas and possess up to 2.5 ounces anywhere in Nevada.
Arizona, like some of the other 23 states with medical-marijuana laws, allows people with valid medical cards from other states to legally possess marijuana in Arizona, but they can’t legally buy it at Arizona dispensaries.
Nevada apparently is the only state that allows its dispensaries to sell to patients from other states. And now its dispensaries have begun to open, greatly expanding where Arizona’s 80,000 patients can legally buy cannabis.
Two Reno-area dispensaries opened in July. Las Vegas saw its first dispensary — Euphoria Wellness — open a couple of weeks ago. More dispensaries in Vegas and elsewhere in Nevada are expected to pop up in the coming months; the state has processed more than 60 dispensary applications.
ALASKA: Shawn, a chef (and expert punster), wonders whether Alaska cannabis regulators have considered his industry as they’re setting the initial boundaries of the legal market.
“I would like to know how they plan to address edibles and establishments that sell them. Are they going to allow a restaurant or dinner club that is an adult atmosphere like a bar, 21 and over, to serve cannabis-infused foods? I’m a chef and I think that we should have opportunity to stake our claim in this ‘budding’ marijuana industry.”
The regulation process is ongoing and regulators are still seeking public input on the draft rules issued so far, so things are a bit fluid at the moment. But it appears that no, Alaska’s current draft regulations don’t take into account the range of likely scenarios involving chefs and the things they might use cannabis for. But that’s not unusual among legalized states. Restaurants haven’t yet been able to go for broke without risk or gray area anywhere in the US.
CALIFORNIA: Gov. Jerry Brown’s administration is crafting the framework for medical marijuana regulations in California, a session-closing play that could end nearly two decades of clashing interpretations and court battles.
With the Legislature scheduled to leave town next week, Brown’s office is said to be bearing down on the details of a compromise medical cannabis measure, legislation that would have implications for the push to place a recreational marijuana legalization initiative on the 2016 statewide ballot.
While Brown’s office is not commenting, legislators and groups with a stake in the issue confirmed over the last week that the Democratic governor’s administration has stepped in to help develop a bill. Last week, legislative leaders stripped the contents of several medical marijuana-related measures and linked them with boilerplate language, establishing a new entry point for Brown’s aides.
SOUTH DAKOTA: This New Year’s Eve, Tony Reider wants to throw a party unlike any his South Dakota tribe has seen.
There will be live music, food, outdoor games—and, floating over the revelry, a haze of marijuana smoke, from a first-of-its-kind pot lounge that is set to open by the end of the year, said Reider, the tribal president of the Flandreau Santee Sioux in Flandreau, S.D.
That pot lounge—modeled on an Amsterdam coffee shop, where customers would be able to buy and smoke up to 2 grams of marijuana a day—would be illegal anywhere else in South Dakota, which, like most U.S. states, bans the sale, possession and public smoking of pot.